Literature DB >> 18608710

Red scrotum syndrome: successful treatment with oral doxycycline.

Ossama Abbas1, Abdul Ghani Kibbi, Adele Chedraoui, Samer Ghosn.   

Abstract

BACKGROUND: Red scrotum syndrome often follows the prolonged application of topical corticosteroids to the scrotal area and is characterized by persistent erythema of the scrotum associated with severe itching, hyperalgesia, and a burning sensation. Several topical and systemic treatments have been used in the past without success.
OBJECTIVE: To assess the efficacy of oral doxycycline, in addition to corticosteroid abstinence, in the treatment of red scrotum syndrome.
METHODS: In a retrospective chart review, seven patients with red scrotum syndrome, who presented between 2004 and 2007 to the outpatient clinic at the American University of Beirut Medical Center, were identified as having been treated with oral doxycycline and steroid abstinence.
RESULTS: All patients reported significant improvement (between 50%and 80%) of their symptoms within 2 weeks of starting doxycycline and had marked improvement of the erythema and complete resolution of symptoms in a period ranging from 2 to 3 months.
CONCLUSION: We suggest that doxycycline may be effective in the treatment of red scrotum syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608710     DOI: 10.1080/09546630802033858

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  4 in total

1.  Red scrotum syndrome.

Authors:  Uwe Wollina
Journal:  J Dermatol Case Rep       Date:  2011-09-21

2.  Carvedilol for the treatment of red scrotum syndrome.

Authors:  Ribal Merhi; Nakhle Ayoub; Marc Mrad
Journal:  JAAD Case Rep       Date:  2017-09-09

3.  Red Scrotum Syndrome Treatment with Pregabalin: A Case Series.

Authors:  Jesus Alberto Cardenas-de la Garza; Cesar Daniel Villarreal-Villarreal; Adrian Cuellar-Barboza; Ramiro Eugenio Cardenas-Gonzalez; Nereyda Gonzalez-Benavides; Luis Gerardo Cruz-Gomez; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  Ann Dermatol       Date:  2019-05-01       Impact factor: 1.444

4.  Treatment of male genital dysesthesia with botulinum toxin.

Authors:  Haya S Raef; Sarina B Elmariah
Journal:  JAAD Case Rep       Date:  2021-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.